Navigation Links
Aurora Capital to Acquire Porex Corporation, Leader in Porous Plastic Materials Science
Date:9/21/2009

LOS ANGELES, Sept. 21 /PRNewswire/ -- Aurora Capital Group ("Aurora"), a Los Angeles-based private equity firm with over $2.0 billion of assets under management, today announced that it has signed a definitive agreement with HLTH Corporation (Nasdaq: HLTH) to acquire its wholly owned subsidiary, Porex Corporation ("Porex" or the "Company"). The transaction is subject to the satisfaction of customary closing conditions and is expected to close in the fourth quarter of this year.

Founded in 1961 and based in Fairburn, GA, Porex is the leading global developer, manufacturer and distributor of porous plastic products. The Company primarily serves the healthcare and surgical end markets, and also supports high-performance applications in the consumer and industrial sectors. Porex products serve filtration, venting, wicking, and diffusing functions in applications such as blood filters, catheter vents, fuel filters, writing instrument tips and consumable diagnostic tests. In addition, through its MEDPOR brand, Porex's surgical products are the first FDA-cleared porous plastic implants for use in craniofacial and orbital reconstructive surgery. Porex, which pioneered porous plastic technology over 40 years ago, is today widely recognized for its materials science expertise and proprietary designs which serve over 1,250 customers across more than 75 countries via operations in North America, Europe and Asia.

Gerald L. Parsky, Chairman of Aurora Capital Group, said, "We are delighted to partner with Porex, the leader in porous plastics. Aurora prides itself on its targeted approach to investing and Porex, with its strong market position, attractive growth opportunities and sustainable profitability, is an excellent fit with our acquisition criteria. I am confident that together we will be able to further strengthen Porex's leading market position and generate continued success for our customers, employees and investors."

John Mapes, Managing Partner of Aurora Capital Group, said, "Porex's unique, proprietary materials expertise supports remarkable product solutions for its customers. We are impressed by the accomplishments of Porex's team and the performance of the company, particularly its resilience during the recent downturn, and look forward to working with management to help the Company continue its commitment to innovation in partnership with its global customer base."

William Midgette, President and Chief Executive Officer of Porex, said, "We are excited to be partnering with Aurora Capital. Aurora's expertise in investing in and guiding market-leading companies, like Porex, will enable us to take our company to the next level of growth and innovation. I am also proud of our 600 plus employees and their dedication to our customers and the Porex mission. I am confident they share my enthusiasm for the significant opportunities that lie ahead for our customers, our company and this partnership."

ABOUT AURORA CAPITAL GROUP

Aurora is a Los Angeles-based private equity firm managing over $2.0 billion that utilizes two distinct investment strategies. Aurora Equity focuses principally on control-investments in middle-market industrial, manufacturing and selected service oriented businesses, each with a leading position in sustainable niches, a strong cash flow profile, and actionable opportunities for both operational and strategic enhancement. Aurora Resurgence invests in debt and equity securities of middle-market companies and targets complex situations that are created by operational or financial challenges either within a company or a broader industry. For more information about Aurora Capital Group, visit www.auroracap.com or www.aurorares.com.

ABOUT HLTH

HLTH Corporation (Nasdaq: HLTH) owns approximately 83% of WebMD Health Corp. (Nasdaq: WBMD). WebMD is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through its public and private online portals and health-focused publications. HLTH also owns Porex, a developer, manufacturer and distributor of porous plastic products and components used in healthcare, industrial and consumer applications.

For Aurora Capital Group:

    Matthew Sherman / Jaime Wert
    Joele Frank, Wilkinson Brimmer Katcher
    (212) 355-4449


'/>"/>
SOURCE Aurora Capital Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HLTH Corporation Announces Agreement to Sell Porex Unit to Aurora Capital Group for $142 Million
2. Aurora Health Care Top Performing Health System in National Quality Initiative
3. Aurora St. Lukes Healing Garden Earns LEED Certification
4. Auroras Milwaukee Hospitals Recognized in US News and World Report
5. Aurora Health Care Sponsors Education Event to Improve Care for the Elderly
6. Leukemia & Lymphoma Society Recognizes Aurora Physician as Man of the Year
7. Aurora Physician Recognized for Multiple Sclerosis Care
8. Aurora St. Lukes Dedicates Rooftop Healing Garden and Conservatory
9. Aurora St. Lukes Dedicates Healing Garden
10. Aurora Health Care Unveils ORBIT, A Cutting-Edge Research Instrument
11. Aurora Health Care Twitter-Surgery A Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Medforce Technologies, Inc., ... to announce it has joined the National Association for Home Care and Hospice ... ill, disabled, and dying Americans of all ages and the caregiver who provide ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., ... (Mobile Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products ... first of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival ... wardrobe. However, for those self-conscious about a double chin, this means more anxiety than ... solution. , “For most people, a double chin is undesirable,” Dr. Goldman said, ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... ... , ... With less than 10,000 dermatologists in the United States and more ... while the desire to conquer breakouts and eliminate skincare stress is widespread. Curology ... today released its inaugural survey on the State of Acne in America. , ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
(Date:3/27/2017)... 27, 2017 Summary This ... Bayer and its partnering interests and activities since 2010. ... an in-depth insight into the partnering activity of one of ... company reports are prepared upon purchase to ensure inclusion of ... The report will be delivered in PDF format within ...
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), ... successfully passed early toxicology and efficacy studies. The company ... target a specific protein, MAGE A, in an effort ... cancer. After 4 weeks of treatment ... show very little toxicity in a full toxicology report ...
Breaking Medicine Technology: